Abstract- 1 -and  2 -adrenergic receptors (ARs) are known to differentially regulate cardiomyocyte contraction and growth. We tested the hypothesis that these differences are attributable to spatial compartmentation of the second messenger cAMP. Using a fluorescent resonance energy transfer (FRET)-based approach, we directly monitored the spatial and temporal distribution of cAMP in adult cardiomyocytes. We developed a new cAMP-FRET sensor (termed HCN2-camps) based on a single cAMP binding domain of the hyperpolarization activated cyclic nucleotide-gated potassium channel 2 (HCN2). Its cytosolic distribution, high dynamic range, and sensitivity make HCN2-camps particularly well suited to monitor subcellular localization of cardiomyocyte cAMP. We generated HCN2-camps transgenic mice and performed single-cell FRET imaging on freshly isolated cardiomyocytes. Whole-cell superfusion with isoproterenol showed a moderate elevation of cAMP. Application of various phosphodiesterase (PDE) inhibitors revealed stringent control of cAMP through PDE4ϾPDE2ϾPDE3. The  1 AR-mediated cAMP signals were entirely dependent on PDE4 activity, whereas  2 AR-mediated cAMP was under control of multiple PDE isoforms.  1 AR subtype-specific stimulation yielded Ϸ2-fold greater cAMP responses compared with selective  2 -subtype stimulation, even on treatment with the nonselective PDE inhibitor 3-isobutyl-1-methylxanthine (IBMX) (⌬FRET, 17.3Ϯ1.3% [ 1 AR] versus 8.8Ϯ0.4% [ 2 AR]). Treatment with pertussis toxin to inactivate G i did not affect cAMP production. Localized  1 AR stimulation generated a cAMP gradient propagating throughout the cell, whereas local  2 AR stimulation did not elicit marked cAMP diffusion. Our data reveal that in adult cardiac myocytes,  1 ARs induce far-reaching cAMP signals, whereas  2 AR-induced cAMP remains locally confined. by the endogenous agonists noradrenaline and adrenaline represents the strongest mechanism to increase cardiac chronotropy and inotropy. 1 The mammalian heart contains 3 AR subtypes: the  1 -, the  2 -, and the  3 AR. The  1 -and  2 AR subtypes dominate the cardiac response to adrenergic stimulation. Both are expressed in cardiomyocytes, couple primarily to G s , and mediate cAMP formation, whereas coupling of the  2 AR to G i has been described in several animal species and in failing human cardiomyocytes. [2][3][4] The second messenger cAMP then leads to activation of protein kinase A (PKA), which phosphorylates key regulators of the cardiac excitation/contraction machinery, including the L-type Ca 2ϩ channel, phospholamban, the ryanodine receptor, and troponin T and I. However, selective stimulation of these 2 receptor subtypes elicits different physiological responses.  1 AR stimulation, but not  2 AR stimulation, seems to induce cardiomyocyte hypertrophy. 5 Transgenic mice with cardiomyocyte-specific overexpression of the  1 AR develop progressive cardiac hypertrophy and heart failure, whereas  2 AR transgenic mice do not show such abnormalities. 6,7 Isolated cardio...